HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Suppression of heat shock protein 27 induces long-term dormancy in human breast cancer.

Abstract
The mechanisms underlying tumor dormancy have been elusive and not well characterized. We recently published an experimental model for the study of human tumor dormancy and the role of angiogenesis, and reported that the angiogenic switch was preceded by a local increase in VEGF-A and basic fibroblast growth factor. In this breast cancer xenograft model (MDA-MB-436 cells), analysis of differentially expressed genes revealed that heat shock protein 27 (HSP27) was significantly up-regulated in angiogenic cells compared with nonangiogenic cells. The effect of HSP27 down-regulation was further evaluated in cell lines, mouse models, and clinical datasets of human patients with breast cancer and melanoma. Stable down-regulation of HSP27 in angiogenic tumor cells was followed by long-term tumor dormancy in vivo. Strikingly, only 4 of 30 HSP27 knockdown xenograft tumors initiated rapid growth after day 70, in correlation with a regain of HSP27 protein expression. Significantly, no tumors escaped from dormancy without HSP27 expression. Down-regulation of HSP27 was associated with reduced endothelial cell proliferation and decreased secretion of VEGF-A, VEGF-C, and basic fibroblast growth factor. Conversely, overexpression of HSP27 in nonangiogenic cells resulted in expansive tumor growth in vivo. By clinical validation, strong HSP27 protein expression was associated with markers of aggressive tumors and decreased survival in patients with breast cancer and melanoma. An HSP27-associated gene expression signature was related to molecular subgroups and survival in breast cancer. Our findings suggest a role for HSP27 in the balance between tumor dormancy and tumor progression, mediated by tumor-vascular interactions. Targeting HSP27 might offer a useful strategy in cancer treatment.
AuthorsOddbjørn Straume, Takeshi Shimamura, Michael J G Lampa, Julian Carretero, Anne M Øyan, Di Jia, Christa L Borgman, Margaret Soucheray, Sean R Downing, Sarah M Short, Soo-Young Kang, Souming Wang, Liang Chen, Karin Collett, Ingeborg Bachmann, Kwok-Kin Wong, Geoffrey I Shapiro, Karl Henning Kalland, Judah Folkman, Randolph S Watnick, Lars A Akslen, George N Naumov
JournalProceedings of the National Academy of Sciences of the United States of America (Proc Natl Acad Sci U S A) Vol. 109 Issue 22 Pg. 8699-704 (May 29 2012) ISSN: 1091-6490 [Electronic] United States
PMID22589302 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • HSP27 Heat-Shock Proteins
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factor C
  • Fibroblast Growth Factor 2
Topics
  • Animals
  • Blotting, Western
  • Breast Neoplasms (genetics, metabolism, pathology)
  • Cell Line, Tumor
  • Cell Proliferation
  • Cells, Cultured
  • Down-Regulation
  • Female
  • Fibroblast Growth Factor 2 (genetics, metabolism)
  • Gene Expression Profiling
  • Gene Expression Regulation, Neoplastic
  • HSP27 Heat-Shock Proteins (genetics, metabolism)
  • Human Umbilical Vein Endothelial Cells (metabolism)
  • Humans
  • Male
  • Mammary Neoplasms, Experimental (genetics, metabolism, pathology)
  • Mice
  • Mice, SCID
  • Neovascularization, Pathologic (genetics)
  • Oligonucleotide Array Sequence Analysis
  • Reverse Transcriptase Polymerase Chain Reaction
  • Time Factors
  • Transplantation, Heterologous
  • Vascular Endothelial Growth Factor A (genetics, metabolism)
  • Vascular Endothelial Growth Factor C (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: